Search Browse Earnings

Vor Biopharma Inc. — SlamSEC

Vor Biopharma Inc.

Nasdaq:VOR

Biological Products, (No Diagnostic Substances)·BOSTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$122.5M

FY 2024

Net Income

-$117.9M

FY 2024

EPS (Diluted)

-$1.75

FY 2024

Stock Price

$16.06

+4.0%

2026-03-10

52W Range

$2.62 – $65.80

P/E Ratio

-9.2x

Market Cap

$167.2M

Cash

$31.4M

FY 2024

Total Debt

—

Net Cash

$31.4M

Enterprise Value

$135.8M

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

-1.1x

Employees

—